ID: ALA5089752

Max Phase: Preclinical

Molecular Formula: C35H65N7O12P2

Molecular Weight: 635.50

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CCN(CC)CC.CCN(CC)CC.Cn1c(=O)n([C@@H]2O[C@H](COP(=O)(O)CP(=O)(O)O)[C@@H](O)[C@H]2O)cc/c1=N/OCc1ccc(C(=O)NCCCCN)cc1

Standard InChI:  InChI=1S/C23H35N5O12P2.2C6H15N/c1-27-18(26-38-12-15-4-6-16(7-5-15)21(31)25-10-3-2-9-24)8-11-28(23(27)32)22-20(30)19(29)17(40-22)13-39-42(36,37)14-41(33,34)35;2*1-4-7(5-2)6-3/h4-8,11,17,19-20,22,29-30H,2-3,9-10,12-14,24H2,1H3,(H,25,31)(H,36,37)(H2,33,34,35);2*4-6H2,1-3H3/b26-18-;;/t17-,19-,20-,22-;;/m1../s1

Standard InChI Key:  PPTAIWVAMWAIIS-TVPBGLRTSA-N

Associated Targets(Human)

5'-nucleotidase 622 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 635.50Molecular Weight (Monoisotopic): 635.1757AlogP: -1.36#Rotatable Bonds: 14
Polar Surface Area: 257.39Molecular Species: ZWITTERIONHBA: 13HBD: 7
#RO5 Violations: 3HBA (Lipinski): 17HBD (Lipinski): 8#RO5 Violations (Lipinski): 3
CX Acidic pKa: 0.98CX Basic pKa: 9.90CX LogP: -2.99CX LogD: -5.03
Aromatic Rings: 2Heavy Atoms: 42QED Weighted: 0.07Np Likeness Score: 0.26

References

1. Scortichini M, Idris RM, Moschütz S, Keim A, Salmaso V, Dobelmann C, Oliva P, Losenkova K, Irjala H, Vaittinen S, Sandholm J, Yegutkin GG, Sträter N, Junker A, Müller CE, Jacobson KA..  (2022)  Structure-Activity Relationship of 3-Methylcytidine-5'-α,β-methylenediphosphates as CD73 Inhibitors.,  65  (3.0): [PMID:35080883] [10.1021/acs.jmedchem.1c01852]

Source